Flagship Ventures Fund V General Partner LLC

CIK 00017245759 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001724575

Recent Transactions

50 trades

Award
Foghorn Therapeutics Inc.$FHTX
Series 1 Warrants to purchase Common Stock
2026-01-13+1,117,734→ 1,117,734 total
Award
Foghorn Therapeutics Inc.$FHTX
Pre-Funded Warrants to purchase Common Stock
2026-01-13$6.71/sh+2,235,468→ 2,235,468 total
Award
Foghorn Therapeutics Inc.$FHTX
Series 2 Warrants to purchase Common Stock
2026-01-13+1,117,734→ 1,117,734 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−4,926,378→ 8,057,470 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−1,181,745→ 0 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−2,825,989→ 8,615,337 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−345,069→ 1,035,208 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−2,431,281→ 7,293,841 total
Other
Sana Biotechnology, Inc.$SANA
Common Stock
2023-09-13−70,813→ 0 total
Disposition from Tender
Sigilon Therapeutics, Inc.
Common Stock
2023-08-11$14.92/sh−113,960→ 0 total
Disposition from Tender
Sigilon Therapeutics, Inc.
Common Stock
2023-08-11$14.92/sh−683,760→ 0 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-06-07$6.24/sh−177,240→ 10,743,293 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-06-07$6.24/sh−22,760→ 1,380,277 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-06-06$6.31/sh−22,297→ 1,403,037 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-06-06$6.31/sh−181,461→ 10,920,533 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-26$6.23/sh−9,330→ 1,425,334 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-26$6.23/sh−72,670→ 11,101,994 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-25$6.35/sh−13,127→ 1,434,664 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-25$6.35/sh−102,245→ 11,174,664 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-24$6.57/sh−39,580→ 1,447,791 total
Sale
Sana Biotechnology, Inc.$SANA
Common Stock
2023-05-24$6.57/sh−308,290→ 11,276,909 total
Purchase
Codiak BioSciences, Inc.
Warrants to purchase Common Stock
2022-09-15+722,590→ 722,590 total
Purchase
Codiak BioSciences, Inc.
Common Stock
2022-09-15+210,743→ 1,188,920 total
Purchase
Codiak BioSciences, Inc.
Common Stock
2022-09-15+722,590→ 1,865,767 total
Purchase
Codiak BioSciences, Inc.
Warrants to purchase Common Stock
2022-09-15+210,743→ 210,743 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−22,275,232→ 0 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-08-03$17.00/sh+220,588→ 8,617,413 total
Conversion
Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-08-03−1,666,666→ 0 total
Conversion
Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-08-03−5,000,000→ 0 total
Conversion
Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-08-03−2,666,667→ 0 total
Conversion
Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-08-03−3,333,333→ 0 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−27,388,000→ 0 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−3,000,000→ 0 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+5,896,386→ 5,896,386 total
Conversion
Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-08-03−666,667→ 0 total
Conversion
Omega Therapeutics, Inc.
Series A Convertible Preferred Stock
2021-08-03−4,112,000→ 0 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+1,323,529→ 1,323,529 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+970,588→ 970,588 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+8,396,825→ 8,396,825 total
Conversion
Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-08-03−1,666,667→ 0 total
Conversion
Omega Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-08-03−13,333,333→ 0 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-08-03$17.00/sh+294,117→ 1,617,646 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-08-03$17.00/sh+661,764→ 5,514,707 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+4,852,943→ 4,852,943 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+1,088,470→ 1,088,470 total
Purchase
Rubius Therapeutics, Inc.
Common Stock
2021-03-19$29.00/sh+70,000→ 15,393,593 total
Purchase
Rubius Therapeutics, Inc.
Common Stock
2021-03-19$29.00/sh+70,000→ 5,859,414 total
Purchase
Rubius Therapeutics, Inc.
Common Stock
2021-03-19$29.00/sh+70,000→ 2,633,703 total
Conversion
Sana Biotechnology, Inc.$SANA
Common Stock
2021-02-08+11,585,199→ 11,585,199 total
Conversion
Sana Biotechnology, Inc.$SANA
Common Stock
2021-02-08+11,441,326→ 11,441,326 total

Companies

Recent Filings

Address

55 CAMBRIDGE PARKWAY, SUITE 800E

CAMBRIDGE, MA, 02142

View on SEC.gov